Lumicera Health Services Selected as a Partner In-Network Specialty Pharmacy for Anzupgo® (delgocitinib) cream
Madison, Wis., September 23, 2025—Lumicera Health Services announced today it will be participating in LEO Pharma’s Limited Distribution Network to dispense Anzupgo® (delgocitinib) Cream, the first and only FDA-approved treatment for moderate-to-severe Chronic Hand Eczema (CHE) in adults.
“Lumicera was selected based on our extensive experience supporting patients with chronic Eczema,” said Ben Heiser, General Manager of Lumicera Health Services. “Being one of the specialty pharmacies given the opportunity to dispense this treatment reflects our commitment to providing the highest level of quality and service to patients with CHE.”
The FDA approval of ANZUPGO® represents a significant milestone for the eczema community by addressing the unmet need for treatment options.
CHE is an inflammatory skin disease with key symptoms of itch and pain that can have a significant psychological and functional impact on patients’ quality of life. CHE affects approximately one in ten adults worldwide.
Lumicera delivers exceptional patient care through a high-touch, personalized approach. This empowers patients with education, personalized guidance, and ongoing assistance throughout their treatment journey. The pharmacy prioritizes affordability and access to specialty medications and directly counsels patients for improved adherence.
Anzupgo® is now available at Lumicera. The full U.S. FDA Prescribing Information and Medication Guide are available here: https://www.leo-pharma.us/AnzupgoPI
About Lumicera Health Services
Lumicera Health Services, a leading specialty pharmacy solutions provider, is a wholly owned subsidiary of Navitus Health Solutions, which is owned by SSM Health and Costco Wholesale Corporation. Founded in 2014, Lumicera is committed to improving specialty pharmacy care, one patient at a time, through educational, clinical, financial and service excellence. This is achieved by bringing clinicians closer to patients and driving positive outcomes through innovative practices and strategic partnerships. For more information, visit www.lumicera.com.